![]() |
![]() |
|
|
Forward to a colleague |
||
Access Full Stories Novo Nordisk and Merck & Co have both indicated they have their eye on expanding their drug discovery and manufacturing presence in India and forging new research partnerships among companies in the country. ... Read ClinPhone declines Parexel's advances Leading eClinical provider ClinPhone has declined a preliminary offer by Parexel to purchase the firm for an undisclosed sum... Read NIH-EPA toxicity agreement promises relief for lab animals A cross-agency agreement that should ease reliance on laboratory animals in testing for environmental toxins and generate data more relevant to humans has been signed by the National Institutes of Health (NIH)... Read Clinical contract news in brief Outsourcing-Pharma.com compiles the news that has featured in the clinical contract community of late, involving Global Research Services, Quintiles and Icon... Read Evotec scores $37m contract expansion Germany's Evotec has scored a three year contract extension with an existing US client worth up to $37m... Read |
||||||||||||||
All News Headlines for: February | January | December |
||||||||||||||
![]() A revolution in Sales Lead Generation! - Free Download Promote your products and technology towards our readers, and we'll build a detailed profile of each person who reads your presentation document... Download our FREE Smart Lead Generation brochure now!... Click Here | ||||||||||||||
|
Related Industry News FDA starts inspecting stalled Watson facility An end may be in sight to the long-running problems with the Florida manufacturing facility acquired by US brand and generic company Watson Pharmaceuticals with Andrx Corporation in November 2006... Read Pfizer expands in inhaled drugs as Nektar cuts back Pfizer's announcement of plans to create a new €130m inhaled medicines unit at its facility in Amboise, France suggests that the firm is still intent on investing in inhalation technology, despite its disappointment... Read Baxter suspends production of heparin after deaths Baxter International has suspended the production of its blood-thinning drug heparin in multi-dose vials, following the deaths of four patients in the USA who were given the drug in high doses... Read FDAs proposed rule on labelling touches pre-emption nerve A proposed rule on labelling changes published by the FDA has re-ignited the reliably inflammable debate over the role of pre-emption in US product liability cases. Critics say the proposal 'shores up the industry's... Read
|
||||||||||||||
|
|||||
Forward to a colleague |
|||||
To continue to receive this newsletter in your inbox, please add newsletter@OutSourcing-Pharma.com to your address book |
||
Update preferences | Change your email address | Unsubscribe |
||
Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback |
||
| © 2008 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com |
||